GALLENGA, Carla Enrica
 Distribuzione geografica
Continente #
NA - Nord America 2.848
AS - Asia 2.062
EU - Europa 1.292
SA - Sud America 362
Continente sconosciuto - Info sul continente non disponibili 131
AF - Africa 64
OC - Oceania 17
Totale 6.776
Nazione #
US - Stati Uniti d'America 2.719
SG - Singapore 706
IT - Italia 447
PL - Polonia 343
CN - Cina 329
BR - Brasile 265
VN - Vietnam 255
HK - Hong Kong 195
BD - Bangladesh 146
DE - Germania 108
GB - Regno Unito 92
IN - India 91
CA - Canada 64
JP - Giappone 60
ID - Indonesia 57
FR - Francia 54
AR - Argentina 42
FI - Finlandia 41
TR - Turchia 39
MX - Messico 36
RU - Federazione Russa 36
TH - Thailandia 32
NL - Olanda 31
UA - Ucraina 30
ES - Italia 25
SE - Svezia 25
IQ - Iraq 19
MY - Malesia 17
CO - Colombia 15
PK - Pakistan 14
VE - Venezuela 14
ZA - Sudafrica 14
AU - Australia 13
EG - Egitto 12
KR - Corea 12
SA - Arabia Saudita 12
PH - Filippine 11
EC - Ecuador 10
IL - Israele 10
AE - Emirati Arabi Uniti 9
BE - Belgio 9
MA - Marocco 9
AT - Austria 8
TN - Tunisia 8
UZ - Uzbekistan 8
CL - Cile 7
GR - Grecia 7
JM - Giamaica 6
KE - Kenya 6
KZ - Kazakistan 6
NP - Nepal 6
RO - Romania 6
AL - Albania 5
CR - Costa Rica 5
LT - Lituania 5
CZ - Repubblica Ceca 4
DZ - Algeria 4
IE - Irlanda 4
JO - Giordania 4
NZ - Nuova Zelanda 4
PY - Paraguay 4
AZ - Azerbaigian 3
HN - Honduras 3
KG - Kirghizistan 3
NI - Nicaragua 3
NO - Norvegia 3
OM - Oman 3
TT - Trinidad e Tobago 3
TW - Taiwan 3
UY - Uruguay 3
BM - Bermuda 2
CI - Costa d'Avorio 2
DO - Repubblica Dominicana 2
GE - Georgia 2
GT - Guatemala 2
LK - Sri Lanka 2
LV - Lettonia 2
LY - Libia 2
SV - El Salvador 2
AM - Armenia 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BH - Bahrain 1
BO - Bolivia 1
BY - Bielorussia 1
CU - Cuba 1
CY - Cipro 1
ET - Etiopia 1
EU - Europa 1
GH - Ghana 1
KW - Kuwait 1
LB - Libano 1
LU - Lussemburgo 1
MD - Moldavia 1
MM - Myanmar 1
MT - Malta 1
NG - Nigeria 1
PE - Perù 1
PS - Palestinian Territory 1
Totale 6.641
Città #
Singapore 423
Ashburn 381
San Jose 349
Warsaw 338
Hong Kong 180
Council Bluffs 173
Santa Clara 135
Fairfield 127
Beijing 115
Chandler 97
Ho Chi Minh City 81
Woodbridge 80
Ann Arbor 75
Houston 68
Los Angeles 65
New York 64
Milan 59
Hanoi 56
Seattle 56
Munich 54
Tokyo 46
Wilmington 46
Cambridge 42
Dallas 38
São Paulo 38
Jakarta 37
Ferrara 35
Pescara 34
Jacksonville 28
Lauterbourg 27
Chicago 26
Denver 26
Toronto 26
Orem 25
Phoenix 24
Rome 23
Mexico City 20
Princeton 20
Helsinki 19
Shanghai 19
Izmir 17
Da Nang 16
Verona 16
Boardman 15
Chennai 15
Atlanta 14
Brooklyn 14
Montreal 14
Buffalo 13
Raipur 13
Redwood City 13
London 12
Turku 12
Haiphong 11
Stockholm 11
Bangkok 10
Bologna 10
Boston 10
Frankfurt am Main 10
Naples 10
San Diego 10
The Dalles 10
Brussels 9
Hefei 9
Johannesburg 9
Norwich 9
Osaka 9
Poplar 9
San Francisco 9
Amsterdam 8
Brasília 8
Curitiba 8
Dong Ket 8
Mumbai 8
Nanjing 8
New Delhi 8
Paris 8
Adelaide 7
Biên Hòa 7
Cagliari 7
Chon Buri 7
Manchester 7
Nuremberg 7
Querétaro 7
Rio de Janeiro 7
Tashkent 7
Buenos Aires 6
Cincinnati 6
Columbus 6
Jeddah 6
Moscow 6
Petaling Jaya 6
Phuket 6
Salt Lake City 6
Turin 6
Ankara 5
Baghdad 5
Bremen 5
Bắc Ninh 5
Cairo 5
Totale 4.120
Nome #
Improving visual activity using Gabor patch technology in Stargardt disease: a retrospective study 467
Determination of the soluble form of the P2X7 receptor in aqueous humour, vitreous humour and serum under normal and pathological conditions: sP2X7R as an indicator of ocular inflammatory status 376
Impact of methylenetetrahydrofolate reductase C677T polymorphism on the efficacy of photodynamic therapy in patients with neovascular age-related macular degeneration 375
Psoriatic uveitis is not an exploded myth 283
Effect of factor XIII-A G185T polymorphism on visual prognosis after photodynamic therapy for neovascular macular degeneration 276
A challenge to the striking genotypic heterogeneity of retinitis pigmentosa: A better understanding of the pathophysiology using the newest genetic strategies 276
Advanced Molecular and Immunological Diagnostic Methods to Detect SARS-CoV-2 Infection 250
A New Pharmacological Approach Based on Remdesivir Aerosolized Administration on SARS-CoV-2 Pulmonary Inflammation: A Possible and Rational Therapeutic Application 231
The role of gene therapy in the treatment of retinal diseases: A review 227
New Insights into Molecular Oncogenesis and Therapy of Uveal Melanoma 206
Diagnosis of a Neonatal Ophthalmic Discharge, Ophthalmia Neonatorum, in the “Molecular Age”: Investigation for a Correct Therapy 204
Impact of TNF and IL-33 Cytokines on Mast Cells in Neuroinflammation 164
How to classify the covid-19 phenotype: a response from "the first soldier in the first trench" in Lombardy, north-western Italy 152
Inflammaging: should this term be suitable for age related macular degeneration too? 151
About Chlamydia trachomatis. Reply to Garcia-Teillard et al. Trachoma and the Importance of Sexual Infective Route in Developed Countries. Comment on “Gallenga et al. Why the SAFE—S Strategy for Trachoma? Are Musca sorbens or Scatophaga stercoraria Really the Culprit?—A Brief Historical Review from an Italian Point of View. Pathogens 2023, 12, 1419” 147
Activation of Mast Cells by Neuropeptides: The Role of Pro-Inflammatory and Anti-Inflammatory Cytokines 143
Evaluation of Anti-SARS-CoV-2 IgA Response in Tears of Vaccinated COVID-19 Subjects 138
Mast cell cytokines il-1, il-33, and il-36 mediate skin inflammation in psoriasis: A novel therapeutic approach with the anti-inflammatory cytokines il-37, il-38, and il-1ra 132
Retinitis pigmentosa and cystoid macular pattern 131
Microglia and mast cells generate proinflammatory cytokines in the brain and worsen inflammatory state: Suppressor effect of IL-37 129
Mast cells mediate rheumatoid arthritis—inhibitory role of IL-37 117
Mast Cell Cytokines in Acute and Chronic Gingival Tissue Inflammation: Role of IL-33 and IL-37 115
Who is Afraid of a Bug Mantled Like Zorro? 111
New insight into systemic mastocytosis mediated by cytokines IL-1β and IL-33: Potential inhibitory effect of IL-37 104
Macrophage Activation in Follicular Conjunctivitis during the COVID-19 Pandemic 103
Why the SAFE—S Strategy for Trachoma? Are Musca sorbens or Scatophaga stercoraria Really the Culprit?—A Brief Historical Review from an Italian Point of View 98
Advances in Mast Cell Activation by IL-1 and IL-33 in Sjögren’s Syndrome: Promising Inhibitory Effect of IL-37 92
Genetic Basis and Molecular Mechanisms of Uveal Melanoma Metastasis: A Focus on Prognosis 88
How to reduce the likelihood of coronavirus-19 (CoV-19 or SARS-CoV-2) infection and lung inflammation mediated by IL-1 83
Progression in migraine: Role of mast cells and pro-inflammatory and anti-inflammatory cytokines 83
Floppy Iris Risk Factors 74
Coronavirus-19 (SARS-CoV-2) induces acute severe lung inflammation via IL-1 causing cytokine storm in COVID-19: a promising inhibitory strategy 65
New aspect of allergic contact dermatitis, an inflammatory skin disorder mediated by mast cells: Can IL-38 help? 64
Gut microbiota and immunity in common variable immunodeficiency: crosstalk with pro-inflammatory cytokines 59
Anaphylaxis is a rare reaction in COVID-19 vaccination 57
Molecular Mechanisms Related to Oxidative Stress in Retinitis Pigmentosa 56
Inquadramento diagnostico dell’Orbitopatia di Graves 54
CAR-T cell therapy causes inflammation by IL-1 which activates inflammatory cytokine mast cells: anti-inflammatory role of IL-37 49
Contribution of mast cells in SARS-CoV-2-induced inflammation 49
Novel evidence of ghrelin and growth hormone segretagogue receptor expression by human ocular tissues 48
Activation of mast cells mediates inflammatory response in psoriasis: Potential new therapeutic approach with IL‐37 45
RETINAL PHAKOMATOSIS AND VON HIPPEL–LINDAU PERIPHERAL CAPILLARY HEMANGIOBLASTOMA: PROPOSAL FOR STAGED SURGERY 44
IL-1 induces throboxane-A2 (TxA2) in COVID-19 causing inflammation and micro-thrombi: inhibitory effect of the IL-1 receptor antagonist (IL-1Ra) 42
Mast cells activated by SARS-CoV-2 release histamine which increases IL-1 levels causing cytokine storm and inflammatory reaction in COVID-19 39
Induction of pro-inflammatory cytokines (IL-1 and IL-6) and lung inflammation by COVID-19: anti-inflammatory strategies 34
Visual Performance and Quality of Life after Femtosecond Laser-Assisted Cataract Surgery with Trifocal IOLs Implantation 33
Interleukin-1 family cytokines and mast cells: activation and inhibition 32
Stimulated mast cells release inflammatory cytokines: potential suppression and therapeutical aspects 31
Suggestions on gut-eye cross-talk: about the chalazion 30
Powerful anti-inflammatory action of luteolin: Potential increase with IL-38 29
Low-grade chronic inflammation mediated by mast cells in fibromyalgia: role of IL-37 27
Mast cells and virus 27
The British variant of the new coronavirus-19 (Sars-Cov-2) should not create a vaccine problem 27
Short term effects of extremely low irradiance photobiomodulation on retinal function, in age related macular degeneration 27
Sodium chromo-glycate and palmitoylethanolamide: A possible strategy to treat mast cell-induced lung inflammation in COVID-19 26
IL-33 mediates allergy through mast cell activation: Potential inhibitory effect of certain cytokines 26
Mesenchymal stem cells and IL-37: a powerful combination 25
Mast cell virus infection and inflammatory cytokines 25
Interrelationship between inflammatory cytokines (IL-1, IL-6, IL-33, IL-37) and acquired immunity 25
New concepts in neuroinflammation: mast cells pro-inflammatory and anti-inflammatory cytokine mediators 23
Mast cells contribute to coronavirus-induced inflammation: new anti-inflammatory strategy 22
Virtual learning solutions in COVID-19 era: University Italian Ophthalmology department perspective 22
SARS-CoV-2, which induces COVID-19, causes Kawasaki-like disease in children: role of pro-inflammatory and anti-inflammatory cytokines 21
Impact of mast cells in fibromyalgia and low‐grade chronic inflammation: Can IL‐37 play a role? 20
Impact of mold on mast cell-cytokine immune response 17
Monoclonal antibody therapy in COVID-19 17
Impact of mast cells in systemic lupus erythematosus: can inflammation be inhibited? 13
Totale 6.776
Categoria #
all - tutte 31.083
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 31.083


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022146 0 0 10 11 8 17 5 13 10 13 13 46
2022/2023244 19 15 13 18 33 25 39 21 29 10 11 11
2023/2024200 14 19 6 9 13 25 8 12 1 15 16 62
2024/2025949 24 20 84 31 95 113 25 45 148 93 120 151
2025/20263.644 278 111 294 525 444 256 337 220 339 433 258 149
2026/2027483 143 218 122 0 0 0 0 0 0 0 0 0
Totale 6.776